AACR Blog Turns 4: How Far Has Immunotherapy Advanced in That Time?

This week marks the fourth anniversary of Cancer Research Catalyst, the official blog of the American Association for Cancer Research (AACR). As outlined in the welcome post from AACR Chief Executive Officer Margaret Foti, PhD, MD (hc), the blog was launched to increase the spread of new knowledge about cancer.

Over these four years, our blog posts have disseminated information about advances across the breadth of cancer research and the clinical cancer care continuum. One area in which advances have occurred at a particularly rapid pace is immunotherapy.

Read More

Disparities in End-of-Life Care

For cancer patients at the ends of their lives, hospice care can provide access to comfort measures and extra help. Medicare offers hospice benefits to eligible patients. But not all patients have equal access to this care, research indicates.

In the spring issue of Cancer Today, medical and business journalist Charlotte Huff writes about disparities in end-of-life care affecting U.S. cancer patients.

Read More

Highlighting Pediatric Preclinical Drug Testing at the Annual Meeting 2018

The AACR’s Pediatric Cancer Working Group, which now boasts over 2,500 members, will hold a special scientific session at the Annual Meeting, where ongoing advances and existing challenges in cancer research will be discussed through the pediatric lens.

Read More

DNA Profiling Moves From Forensics to Diagnostics

Television series like CSI: Crime Scene Investigation familiarized viewers with advances in forensic science that allow investigators to detect minute amounts of a person’s unique DNA sequence found at a crime scene and analyze it to implicate or exonerate a suspect. Similar DNA technologies can also detect and analyze small numbers of cancer cells in blood.

Read More

Can Molecular Analysis be Tapped to Tackle Brain Cancer?

Compared to treatment advances for other types of cancer, progress in treating brain cancer has been frustratingly slow. Still, understanding the molecular changes that drive brain cancer remains “potentially transformative,” says Paul Mischel, a cancer biologist and neuropathologist at the Ludwig Institute for Cancer Research in San Diego.

Read More

Fostering New Advances in Lung Cancer Research

A diverse group of about 220 physicians, patient advocates, and scientists in basic, translational, and clinical lung cancer research will convene in San Diego for an international conference organized by the American Association for Cancer Research (AACR) and the International Association for the Study of Lung Cancer (IASLC). The focus of the conference is “Lung Cancer Translational Science from the Bench to the Clinic.”

Read More

Biosimilars: Breaking Through to Cancer Treatment

A little-talked-about provision of the 2010 Patient Protection and Affordable Care Act designed to improve access to innovative medical therapies has recently borne fruit for the cancer community in the form of two new therapeutic options for a wide range of cancers—bevacizumab-awwb (Mvasi) and trastuzumab-dkst (Ogivri).

Read More